Akebia Therapeutics AKBA
NASDAQ AKBA
$0.57 +0.03 (+5.89%)
At close: Nov 11, 2026 · 4:00 PM EST

Akebia Therapeutics (AKBA) Deferred Taxes (2019)

Updated

Akebia Therapeutics (AKBA) reported Deferred Taxes of -$6.63 million for FY2019, compared with -$28.47 million in FY2018.

Analysis

Akebia Therapeutics (AKBA) Deferred Taxes (2019) Analysis & Trends

  • According to Business Quant data, Deferred Taxes came in at -$28.47 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.79 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -56.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 202.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -860.00 Mn
10 Akebia Therapeutics 149.86 Mn -512.48 Mn 30.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -1.75 Mn
Sep 30, 2019 -1.28 Mn
Jun 30, 2019 -845,000.00
Mar 31, 2019 -2.76 Mn
API Access

Akebia Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=AKBA&period=max&api_key=YOUR_API_KEY